Rivals Merck & Co., Inc. (MRK), Roche (RHHBY) Team Up on Hepatitis C Drugs, Raising Ante in Vertex Pharmaceuticals (MA) (VRTX) Rivalry More...
Bristol-Myers Squibb Company (BMY) Expands Deal to Evaluate Tekmira Pharmaceuticals Corporation's RNAi Delivery Technology More...
Bristol-Myers Squibb Company (BMY) Expands Deal to Evaluate Tekmira Pharmaceuticals Corporation's RNAi Delivery Technology More...
• Foundation Medicine Announces Clinical Cancer Genomics Collaboration with Celgene Corporation (CELG) More...
• ERYtech Pharma to Partner with Teva Pharmaceutical Industries Limited (TEVA) for Long Term Distribution Agreement in Israel More...
• Opexa Pharmaceuticals, Inc. Executes Strategic Service Agreement with the American Red Cross More...
• Inspire Pharmaceuticals, Inc. (ISPH) CEO, Workers Out as Merck & Co., Inc. (MRK) Closes Inspire Headquarters More...
• Pharmascience Inc. Strengthens its Leadership Position in Quebec's Pharmaceutical Sector, Creation of 180 Jobs by 2012 More...
• SciFluor Life Sciences Launches with $5M Seed Funding More...
• Resolve Therapeutics Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A More...
• Benitec, Inc. (BLT.AX) Raises AU$8 Million ($8.5 Million) to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed More...
• Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Adds $6.9M More...
• VistaGen Therapeutics, Inc. and Excaliber Enterprises Announce Completion of Reverse Merger and $3.8 Million Financing More...
• CytRx Corporation (CYTR) Sells Molecular Chaperone Drugs by Spinning Off Non-Core Assets in Deal Worth up to $120 Million More...
• Rules-Based Medicine, Inc. Acquires Intellectual Property Assets of Satoris Inc. More...
• inVentiv Health (VTIV) to Acquire PharmaNet, Inc. More...
• Astellas Pharma Inc. (YPH.BE), Maxygen, Inc. (MAXY) Announce Completion of Acquisition of Perseid by Astellas for $76 Million More...
• The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific OfficerMore...
• Xanodyne Pharmaceuticals, Inc. Appoints New Chief Operating Officer More...
• Cerulean Pharma Inc. Appoints Chief Medical Officer,Edward Garmey, M.D. More...
• Former Pharma Executive, Dr. Dominique Bridon, JoinsOptivia Senior Management More...
• Mucosis B.V. Appoints Thomas Johnston As Chief Business Officer More...
• Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Second Quarter Fiscal Year 2011 Results More...
• Adeona Pharmaceuticals (AEN) Reports 1st Quarter 2011 Financial Results More...
• Aastrom Biosciences, Inc. (ASTM) Reports First Quarter 2011 Financial Results and Corporate Developments More...
• Ark Therapeutics Interim Management Statement More...
• Bio-Path Holdings, Inc. (BPTH) Reports First Quarter 2011 Financial ResultsMore...
• Origin Agritech Limited (SEED) Establishes Second State-of-the-Art Seed Production Center, Expanding Western Channels and Doubling Seed Production Capacity More...
• More Signs Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Diabetes Drug, Actos Linked to Bladder Cancer More... • Prostate Cancer Foundation Denosumab May Prolong Metastasis-Free Survival in Men with High-Risk Prostate Cancer More... • GTx, Inc. (GTXI) Presents Preclinical Study Results Demonstrating That Capesaris (TM) (GTx-758) Chronic Treatment Does Not Cause Gynecomastia in Male Primates More... • DBV Technologies Demonstrates Ability of VIASKIN® to Administer Allergen via Intact Skin by Targeting Dendritic Cells for Safe Treatment of Allergic DiseaseMore... • EnVivo Pharmaceuticals, Inc. Announces Positive Phase 2b Clinical Data in Schizophrenia: EVP-6124 Meets Primary Endpoint with Statistically Significant Improvement in Cognition and Multiple Secondary Endpoints for Improvement in Function and Impact on Negative Symptoms More... • Can Selenium Lower Cholesterol?- University of Surrey Study More... • Abcc10 May Be Effective in Extending the Effectiveness of Anticancer Drugs,Fox Chase Cancer Center Study More... • Protein Could Offer Target to Reduce Lung Damage from Smoking-Caused Emphysema, Indiana University Study More... • New Study Dramatically Cuts Treatment for Latent TB, Centers for Disease Control and Prevention (CDC) Study More... • Cytheris SA and Cancer Immunotherapy Trials Network (CITN) Announce Selection of Recombinant Interleukin-7 (CYT107) for Initial Studies at Member Institutions More... ( Source: Biospace ) |
News
0 comments